Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti-Programmed Death 1 Immunotherapy for Recurrent Liver Tumors.
Shi GM, Wang J, Huang XW, Huang XY, He YF, Ji Y, Chen Y, Wu D, Lu JC, Sun QM, Liu WR, Wang T, Yang LX, Hou YY, Shi YH, Sun J, Xiao YS, Wang Z, Fan J, Bertagnolli MM, Zhou J.
Shi GM, et al. Among authors: wang j, wang z, wang t.
Liver Transpl. 2021 Feb;27(3):444-449. doi: 10.1002/lt.25887. Epub 2020 Dec 5.
Liver Transpl. 2021.
PMID: 32897657
No abstract available.